Exelixis, Inc. EXEL
NASDAQ · United States · Health Technology
$58.41-0.24 (-0.41%)
Market closed· · USD · Data may be delayed
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-05 | 0.91 | 0.85 | +6.6% | $628.69M | -1.2% | -6.8%$56.00→$52.20 |
| Q1 2026 | 2026-05-05 | 0.87 | 0.76 | +14.5% | — | — | +10.3%$44.17→$48.70 |
| Q4 2025 | 2026-02-10 | 0.94 | 0.81 | +16.0% | — | — | -2.3%$43.95→$42.94 |
| Q3 2025 | 2025-11-04 | 0.78 | 0.67 | +16.4% | — | — | +6.1%$38.06→$40.37 |
| Q2 2025 | 2025-07-28 | 0.75 | 0.65 | +15.4% | — | — | — |
| Q1 2025 | 2025-05-13 | 0.62 | 0.44 | +40.9% | — | — | — |
| Q4 2024 | 2025-02-11 | 0.55 | 0.49 | +12.2% | — | — | — |
| Q3 2024 | 2024-10-29 | 0.47 | 0.42 | +11.9% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.